| Market Cap | ₹2,149Cr |
| ROE | 15.56% |
| P/E Ratio(TTM) | 39.42 |
| EPS(TTM) | 18.86 |
| P/B Ratio | 6.58 |
| Dividend Yield | 0.62% |
| Industry P/E | 41.00 |
| Book Value | 112.97 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | Amrutanjan Health Care Limited |
| Managing Director | Mr. S. Sambhu Prasad |
| NSE Symbol | AMRUTANJAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.85 | ||
| Gland Pharma | NA (0.00%) | 40.72 | ||
| Ajanta Pharma | NA (0.00%) | 33.06 | ||
| Eris Lifesciences | NA (0.00%) | 53.97 |